$0.00
(Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
7 Years Aggregate
CFO
$-56.43 Mln
EBITDA
$-74.42 Mln
Net Profit
$-51.96 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
PAVmed Inc (PAVMW)
| -82.9 | -85.5 | -98.1 | -94.2 | -58.5 | -60.5 | -- |
|
BSE Sensex*
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout PAVmed Inc (PAVMW)
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of... adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York. Read more
-
Chairman & CEO
Dr. Lishan Aklog M.D.
-
Chairman & CEO
Dr. Lishan Aklog M.D.
-
Headquarters
New York, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for PAVmed Inc (PAVMW)
What is the current share price of PAVmed Inc (PAVMW) Today?
The share price of PAVmed Inc (PAVMW) is $0.03 (NASDAQ) as of 28-Jan-2022 12:36 EDT. PAVmed Inc (PAVMW) has given a return of -58.51% in the last 3 years.
What is the current PB & PE ratio of PAVmed Inc (PAVMW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2020 |
-303.24 |
5.74 |
2019 |
-- |
-- |
2018 |
-1.01 |
-7.87 |
2017 |
-- |
-- |
2016 |
-- |
-- |
What is the 52 Week High and Low of PAVmed Inc (PAVMW)?
The 52-week high and low of PAVmed Inc (PAVMW) are Rs -- and Rs -- as of 02-Sep-2026.
What is the market cap of PAVmed Inc (PAVMW)?
PAVmed Inc (PAVMW) has a market capitalisation of $ 1 Mln as on 14-Feb-2022. As per SEBI classification, it is a company.
Should I invest in PAVmed Inc (PAVMW)?
Before investing in PAVmed Inc (PAVMW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.